Forte Biosciences (FBRX)
(Delayed Data from NSDQ)
$0.53 USD
-0.02 (-3.44%)
Updated Aug 2, 2024 04:00 PM ET
After-Market: $0.53 0.00 (-0.02%) 7:58 PM ET
3-Hold of 5 3
D Value C Growth D Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/12/24 |
---|---|
Current Quarter | -0.16 |
EPS Last Quarter | -0.16 |
Last EPS Surprise | NA |
ABR | 1.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -0.59 |
Next Year | -0.55 |
EPS (TTM) | -0.88 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | NA |
# of Estimates | NA | NA | NA | NA |
High Estimate | NA | NA | NA | NA |
Low Estimate | NA | NA | NA | NA |
Year ago Sales | 0.00M | 0.00M | NA | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.16 | -0.17 | -0.59 | -0.55 |
# of Estimates | 1 | 1 | 3 | 3 |
Most Recent Consensus | -0.16 | -0.17 | -0.66 | -0.68 |
High Estimate | -0.16 | -0.17 | -0.51 | -0.43 |
Low Estimate | -0.16 | -0.17 | -0.66 | -0.68 |
Year ago EPS | -0.42 | -0.26 | -1.00 | -0.59 |
Year over Year Growth Est. | 61.90% | 34.62% | 41.00% | 7.91% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.16 | -0.17 | -0.59 | -0.55 |
7 Days Ago | -0.16 | -0.17 | -0.59 | -0.55 |
30 Days Ago | -0.16 | -0.17 | -0.59 | -0.55 |
60 Days Ago | -0.16 | -0.17 | -0.59 | -0.55 |
90 Days Ago | NA | NA | -0.46 | -0.45 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.16 | -0.17 | -0.59 | -0.55 |
Zacks Consensus Estimate | -0.16 | -0.17 | -0.59 | -0.55 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.16 | -0.04 | -0.26 | -0.42 | NA |
Estimate | NA | NA | NA | NA | NA |
Difference | NA | NA | NA | NA | NA |
Surprise | NA | NA | NA | NA | NA |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more